How does clinical trial efficacy work (simply put)?

Post date: 2020-12-02 13:05:54
Views: 208
Confused about the data provided on the recent COVID studies, and why they mean vaccines were judged to be 95% effective

The Pfizer and Moderna press releases (Pfizer's linked here) provide three main pieces of data: the number of trial participants, the number of participants who contracted the virus, and the number of participants contracting the virus who were in the control group, receiving a placebo. (Apologies for any mistakes in terminology or anything else I'll be making here.)

So for Pfizer's trial, there were more than 43,000 participants, 170 of them contracting COVID, and 8 of them were in the vaccine group, meaning 162 were in the placebo group. 8/162 is ~5%.

The press releases don't say that this is why the vaccines are judged to be 95% effective, though papers like the Washington Post connect the dots. But how is this not the wrong way to judge effectiveness? Wouldn't the right way be to say 162 out of 16,200, e.g., taking the placebo contracted it, and that's 1%, and 8 of let's say 16,200 receiving the vaccine contracted it, and that's 5% of 1%, meaning the vaccine is 95% effective?
Number of Comments
Please click Here to read the full story.
 
Other Top and Latest Questions:
Hidden beneath AI chips, Chinese-made circuit boards raise national security concerns in U.S.
Trump's 'big beautiful bill' has a 'double taxation' trap for top earners, tax lawyers say
CrowdStrike narrowly beats estimates on AI tailwinds, but stock falls 10%
Barclays traders say it's time to buy protection for a tech-led S&P 500 pullback
As Honeywell Aerospace readies for its stand-alone debut, its CEO is forecasting big growth
Dell Optiplex with Kubuntu
Movie: Escape from Alcatraz
Here are Thursday's biggest analyst calls: Nvidia, Apple, Broadcom, Netflix, Oracle, Microsoft, CrowdStrike & more
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
Oil prices fall 3% on report Trump reluctant to restart Iran war